Denis Corin is Chief Executive Officer of Q BioMed Inc.. Currently has a direct ownership of 2.64 Million shares of QBIO, which is worth approximately $0. The most recent transaction as insider was on May 26, 2022, when has been sold 200,000 shares (Common Stock) at a price of $20000.0 per share, resulting in proceeds of $4,000,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.64M
0% 3M change
0% 12M change
Total Value Held $0

Denis Corin Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 26 2022
BUY
Grant, award, or other acquisition
$4,000,000,000 $20000.0 p/Share
200,000 Added 7.04%
2,641,800 Common Stock
DC

Denis Corin

Chief Executive Officer
Grand Cayman, E9

Track Institutional and Insider Activities on QBIO

Follow Q BioMed Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QBIO shares.

Notify only if

Insider Trading

Get notified when an Q Bio Med Inc. insider buys or sells QBIO shares.

Notify only if

News

Receive news related to Q BioMed Inc.

Track Activities on QBIO